# Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

> **NCT00446511** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 250 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan
- **DRUG:** Enalapril
- **DRUG:** placebo matched to enalapril
- **DRUG:** placebo matched to valsartan

## Key facts

- **NCT ID:** NCT00446511
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446511, "Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00446511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*